Genetic and Metabolic Neonatal Epilepsies

Pediatric Annals
|June 11, 2021
PubMed

Insights

Neonatal seizures, often genetic or metabolic, require accurate diagnosis for effective treatment. This study proposes a diagnostic approach to identify and manage these complex neurological disorders in newborns.

Area of Science:

  • Neonatal Neurology
  • Clinical Genetics
  • Epileptology

Background:

  • Neonatal seizures are common neurological disorders, affecting 1-5 per 1,000 live births.
  • Genetic and metabolic epilepsies constitute 10-12% of all neonatal seizures.
  • Accurate diagnosis is crucial for guiding treatment and management strategies.

Purpose of the Study:

  • To propose a step-wise diagnostic approach for genetic and metabolic epilepsies in neonates.
  • To aid clinicians in the care of newborns presenting with seizures.
  • To differentiate between treatable metabolic disorders and common genetic epilepsies.

Main Methods:

  • Utilizing clinical history and neurological examination findings.
  • Analyzing seizure types, epilepsy syndromes, and electroencephalogram (EEG) results.
  • Categorizing neonatal epilepsies into treatable and common genetic forms.

Main Results:

  • Identified inborn errors of metabolism as primary treatable disorders.
  • Highlighted monogenic disorders (channelopathies, synaptic defects, signaling dysfunction) as common genetic epilepsies.
  • Emphasized the importance of a structured diagnostic pathway.

Conclusions:

  • A systematic diagnostic approach is essential for managing neonatal seizures.
  • Distinguishing between treatable and common genetic epilepsies improves patient outcomes.
  • This framework supports clinicians in diagnosing and treating neonatal epilepsy.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
575
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
430
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
845
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
48
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.0K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
629